address:
Service points are available in Shenzhen, Hong Kong, Japan, Boten, Kyrgyzstan, Russia, and the United States.
microsoft
zj2017122
Phone:
13902458366
For business inquiries or to obtain the latest industry quotes, please scan the QR code or add the WeChat ID below. We will provide you with one-on-one exclusive service.
Awareness of FDA-Related Rules | CLIA Quality Standard Laboratory Pathway | HIPAA Privacy Rule Framework | Early Legal Involvement
Standard test tube automated lines cannot directly process cases related to infectious diseases. What HIV-infected individuals truly need is a complete pathway including virus control, sperm washing, laboratory isolation management, and compliant embryo creation.
By washing sperm, processing samples, and performing PCR nucleic acid testing, the risk of transmission can be minimized before proceeding to more controllable assisted reproductive pathways such as IVF/ICSI.
Common steps include: density gradient centrifugation for layered purification, upstream purification of motile sperm, and post-processing sample verification to ensure the sample meets the requirements of the receiving center before proceeding to subsequent fertilization or embryo formation processes.
The key is not to rush to retrieve eggs, but to first stabilize and control the viral load before assessing whether to proceed with the egg retrieval, embryo creation, and surrogacy process.
In the early stages, it is important to focus on viral load, CD4 count, treatment adherence, and overall infection management. Prioritize pre-pregnancy preparation before deciding on the next steps.
Egg retrieval and embryo culture are performed in an independent laboratory environment that can receive HIV cases, avoiding the mixing of infectious disease samples into the regular test tube production line.
If third-party assisted reproduction (surrogacy) is involved, the key is to handle pregnancy risks, informed consent from the surrogate mother, and legal documents all in advance to form a complete closed loop.
HIV cases should not be judged solely by "which country legalizes surrogacy," but also by whether clinics accept the procedure, whether laboratories are capable of performing it, whether the surrogate mother is informed and accepts the procedure, and whether lawyers are willing to provide written opinions.
Families seeking stable processes, a closed legal loop, standardized sample management, and more comprehensive privacy management.
Families who are more concerned about cost-effectiveness but are willing to accept case-by-case evaluation, center screening and lawyer pre-verification.
Except for cases involving special infectious diseases, the surrogacy process typically includes basic expenses.
The additional costs commonly associated with HIV infection are often not included in standard quotes.
A word of advice: What you really need to be wary of is not "high prices", but rather prices that start low and then rise, with each additional step increasing the price. Instead of just looking at the total price on the homepage, it's better to ask clearly before signing the contract: what are the basic packages, and what are the special additional items that only occur in HIV cases, especially sample processing, laboratory isolation, surrogate mother matching, and embryo transfer verification.
First, we need to check the viral load, CD4 count, and treatment status. This is the first hurdle to overcome before we can proceed.
First, confirm whether this center accepts HIV-assisted reproduction/IVF for people with HIV. Don't ask about the price first; ask if it's even possible.
If the male tests positive: focus on sperm washing, sample processing, and PCR nucleic acid testing; if the female tests positive: focus on viral load control, egg retrieval, and embryo establishment conditions; if there are already embryos: focus on whether they can still be received.
Before engaging in surrogacy, ensure the surrogate mother's informed consent, obtain independent legal counsel, and complete a closed-loop contract. If the order is incorrect, problems can easily arise later.
Only after all the previous steps are approved can the matching and transplantation process begin. This stage focuses on informed consent, complete contractual agreements, and teamwork.
Getting pregnant is not the end. Prenatal checkups, childbirth, parentage documents, and the chain of documents for returning to China all need to be arranged in advance.
Treat U=U as an important premise, not the end point. First, confirm the laboratory acceptance standards, legal opinions, and informed consent pathways for pregnant women, and then proceed with subsequent medical arrangements.
First, conduct legal and procedural verifications before initiating any critical medical actions. Ensuring that the clinic, lawyers, and the pregnant woman's pathway are all feasible is the truly prudent order of action.
The truly stable approach is to ensure that clinics, lawyers, and expectant mothers are all informed within acceptable limits. For highly sensitive projects, transparency and compliance are always more important than "getting away with it."
First, have the receiving laboratory assess the source of the embryos, the background of embryo formation, the freezing records, and the feasibility of transportation. Once it is confirmed that they can accept the embryos, then we can discuss the advancement of surrogacy.
Before signing the contract, review the basic and additional packages separately, and confirm each item: which items are already included, which are charged per use, and which will be added again if there is a failure or restart.
An assessment can be conducted, but not everyone can be directly initiated. The final decision on whether to proceed is not solely based on the "HIV positive" label, but rather on a comprehensive evaluation. Virus control status, laboratory acceptance, informed consent from the pregnant woman, destination access rulesTherefore, the key to these types of cases is not to rush things forward, but to conduct both compliance and medical assessments first.
In most pathways, semen washing and sample processing are core steps. Their purpose is not to create a "formal workflow," but rather to achieve... Sperm washing, sample purification, PCR nucleic acid detection and verification By taking measures such as these, the risk of transmission can be minimized before proceeding to more controllable assisted reproductive processes such as IVF/ICSI.
No. U=U is certainly important; it represents better virus control, but it doesn't mean that additional screening in assisted reproduction and surrogacy can be skipped. HIV cases still need to go through the necessary procedures. Laboratory acceptance standards, sample management requirements, legal document review and process verification"U=U" should not be directly interpreted as "automatic release at all stages".
Not necessarily. Many used embryos cannot be seamlessly transferred between clinics or across borders. The recipient will usually review them again first. Embryo preparation laboratory background, sample source records, infectious disease case handling procedures, freezing and transportation documentsOnly after confirming that the criteria are met can the surrogacy process proceed.
Generally not. Birth certificates usually belong to... Civil registration documentsThe birth certificate primarily records the time and place of birth and parents' information, rather than a complete medical record. In other words, under normal circumstances, HIV history will not be directly stated on the baby's birth certificate.